From: Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
hsa-miR-122-5p | ||||
Cut-off | HR | 95% CI | p value | |
Overall survival | 5.89 | 5.11 | 1.456–17.93 | 0.010 |
Cancer-specific survival | 5.89 | 8.146 | 1.915–34.66 | 0.004 |
Progression-free survival | 5.89 | 3.632 | 1.416–9.318 | 0.007 |
hsa-miR-206 | ||||
Cut-off | HR | 95% CI | p value | |
Overall survival | 2.787 | 6.037 | 1.614–22.58 | 0.007 |
Cancer-specific survival | 2.787 | 8.15 | 1.938–34.27 | 0.004 |
Progression-free survival | 2.382 | 4.98 | 1.952–12.7 | < 0.001 |